Nondiagnostic thyroid fine needle aspiration cytology: Outcome in surgical treatment

Revista de Investigacion Clinica

Volumn 59, Issue 3, 2007, Pages 180-183

  Tamez Pérez, Héctor Eloy ^a,b   Gutiérrez Hermosillo, Hugo ^a   Forsbach Sánchez, Gerardo ^a   Gómez de Ossio, María Dolores ^a   González González, Gerardo ^b   Guzmán López, Santos ^b   Tamez Peña, Alejandra Lorena ^b   Mora Torres, Nishmy Eloísa ^a   González Murillo, Eduardo Alfredo ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Fine needle aspiration; Follicular neoplasm; Thyroid cancer; Thyroid cytology; Thyroid nodule; Thyroid surgery

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENDER BIAS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PREDICTION; RETROSPECTIVE STUDY; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; TREATMENT OUTCOME;

ADENOCARCINOMA, FOLLICULAR; ADULT; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; THYROID DISEASES; THYROID NEOPLASMS; THYROID NODULE; THYROIDECTOMY; UNNECESSARY PROCEDURES;

EID: 34548785058     PISSN: 00348376     EISSN: 00348376     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Castro M, Castro MD, Hossein G. Continuing Controversies in the Management of Thyroid Nodules. Ann Intern Med 2005; 142: 926-31.
2. AACE/AME Task Force on Thyroid Nodules. Endocr Pract 2006; 12: 63-102.
3. Hegedus L. Clinical practice: the thyroid nodule. N Engl J Med 2004; 351: 1764-71.
4. Chow LS, Gharib H, Goellener JR, van Heerden JA. Non diagnostic thyroid fine needle aspiration cytology: management dilemmas. Thyroid 2001; 11: 1147-51.
5. Saggiorato E, Cappia. S, De Giuli P, Massa A. Galectin 3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin End Met 2001; 86: 5152-8.
6. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter; current status and future perspectives. Endocr Rcv 2003; 24: 102-32.
7. Stephenson TJ. Prognostic and predictive factors in endocrine turnouts. Histopathology 2006; 48: 629-43.
8. Sherman S. Thyroid carcinoma. Lancet 2003; 361: 501-11.
9. Greaves T, Olvera M, Florentine B, Raza A. Follicular Lesiones of thyroid, a 5 year fine needle aspiration experience. Cáncer Cytopathol 2000; 90: 337-41.
10. Kovacs RB, Foldes J, Winkler G, Bodo M, Sapi Z. The investigation of Galectin 3 in diseases of the thyroid gland. Eur J End 2003; 149: 449-53.
11. Sahin M, Gursoy A, Tutuncu NB, Guvener N. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clinical Endocrinology 2006; 65: 514-18.
12. Bartolazzi A, Papotti M, Bussolatt G. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001; 357: 1644-50.
13. Bernet V, Anderson J, Vaishnav Y, Salomon B. Determination of Galectin 3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription polymerase chain reaction. J Clin End Metab 2002; 87: 4792-6.
14. Coli A, Bigotti G, Zucchetti F. Galectin 3, a marker of well differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 2002; 40: 80-7.
15. Sebo JT, Castro MR, Gharib H. Thyroid nodules: a systematic and cost-effective approach. Endocrinology Update 2006; 1: 3-4.